Zobrazeno 1 - 10
of 30
pro vyhledávání: '"E. Kutarska"'
Autor:
J.A. Ledermann, B. Zurawski, F. Raspagliesi, U. De Giorgi, J. Arranz Arija, M. Romeo Marin, A. Lisyanskaya, R.L. Póka, J. Markowska, C. Cebotaru, A. Casado Herraez, N. Colombo, E. Kutarska, M. Hall, A. Jacobs, I. Ahrens-Fath, H. Baumeister, A. Zurlo, J. Sehouli
Publikováno v:
ESMO Open
Background Gatipotuzumab is a humanized monoclonal antibody recognizing the carbohydrate-induced epitope of the tumor-associated mucin-1 (TA-MUC1). This study aimed to evaluate the efficacy and safety of switch maintenance therapy with gatipotuzumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21dafef0b1578b36428d940a42d27a97
https://hdl.handle.net/10281/403233
https://hdl.handle.net/10281/403233
Autor:
A. Casado Herraez, Cristina Ligia Cebotaru, Alfredo Zurlo, Riccardo Belli, Alla Lisyanskaya, Nicoletta Colombo, F. Raspagliesi, Jalid Sehouli, M. Romeo Marin, U. De Giorgi, Marcia Hall, S. Mihutiu, Róbert Póka, Janina Markowska, B. Zurawski, J.A. Arranz Arija, Jonathan A. Ledermann, N. Kovalenko, Susana Banerjee, E. Kutarska
Publikováno v:
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f8bd238e689e748849ae583d35aaaa
https://doi.org/10.1093/annonc/mdx440.035
https://doi.org/10.1093/annonc/mdx440.035
Autor:
R.W. Naumann, E. Kutarska, Mariusz Bidziński, Reshma A. Rangwala, K. Anderson, Chandra D. Lovejoy
Publikováno v:
Gynecologic Oncology. 133:177-178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2d0a6d48e1d02c7bfc36d913760e8f4
https://doi.org/10.1016/j.ygyno.2014.03.468
https://doi.org/10.1016/j.ygyno.2014.03.468
Autor:
Patricia Pautier, E. Kutarska, Florence Joly, M. Shoaib, Natacha Heutte, V. Ostapenko, John Green, Z. Zvirbule, Ana Oaknin, Geoffrey Hall, Ignace Vergote, A. Lisayankaya, Bohuslav Melichar, Nicholas S. Reed, E. Chetaille
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2015, 51, pp.S541. ⟨10.1016/S0959-8049(16)31498-8⟩
European Journal of Cancer, Elsevier, 2015, 51, pp.S541. ⟨10.1016/S0959-8049(16)31498-8⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc85e1a356645f494e4ae556f272f1fd
https://doi.org/10.1016/s0959-8049(16)31498-8
https://doi.org/10.1016/s0959-8049(16)31498-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas J. Herzog, R.W. Naumann, James T. Symanowski, E. Kutarska, Mariusz Bidziński, Reshma A. Rangwala, Binh Nguyen
Publikováno v:
Gynecologic Oncology. 133:178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab6e0a0463e5165eaadcb14da6688764
https://doi.org/10.1016/j.ygyno.2014.03.469
https://doi.org/10.1016/j.ygyno.2014.03.469
Publikováno v:
Annals of Oncology. 23:ix329
Background Despite the progress in the diagnosis and therapy of early EC, advanced (metastatic) or recurrent EC remains an incurable disease. Irosustat (also known as BN83495, STX64 and 667-coumate) is a selective irreversible STS inhibitor developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b9ef4a2d560ad573121282a76db7dca
https://doi.org/10.1016/s0923-7534(20)33559-6
https://doi.org/10.1016/s0923-7534(20)33559-6
Autor:
R. W. Naumann, R. L. Coleman, R. A. Burger, T. J. Herzog, R. Morris, E. A. Sausville, E. Kutarska, S. A. Ghamande, N. Y. Gabrail, S. De Pasquale, E. Nowara, L. Gilbert, J. R. Caton, R. H. Gersh, M. G. Teneriello, W. A. Harb, P. Konstantinopoulos, J. T. Symanowski, C. Lovejoy, R. A. Messmann
Publikováno v:
Journal of Clinical Oncology. 29:5045-5045
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02c988bde33298d069e66eaceebf5c39
https://doi.org/10.1200/jco.2011.29.15_suppl.5045
https://doi.org/10.1200/jco.2011.29.15_suppl.5045
Autor:
P. Koralewski, M.A. Sroehlein, Simon L. Parsons, Alexander Burges, Pauline Wimberger, E. Kutarska, M.M. Heiss, H. Friccius-Quecke, M. Jaeger, Martin Gore
Publikováno v:
European Journal of Cancer Supplements. 5:311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::890b1e92d1858ca202da6ce8e9c0bce7
https://doi.org/10.1016/s1359-6349(07)71173-4
https://doi.org/10.1016/s1359-6349(07)71173-4
Autor:
P. Koralewski, Pauline Wimberger, Alexander Burges, Martin Gore, Angelika Lahr, M. A. Stroehlein, M. Jaeger, E. Kutarska, Markus M. Heiss, Simon L. Parsons
Publikováno v:
Journal of Clinical Oncology. 25:5520-5520
5520 Background: Malignant ascites in ovarian carcinoma patients (pts.) is associated with a poor prognosis and reduced quality of life. Catumaxomab (anti-EpCAM × anti-CD3) is known to effectively eliminate tumor cells within ascites by simultaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2574e61fa20371f71c41d0bcb25345d
https://doi.org/10.1200/jco.2007.25.18_suppl.5520
https://doi.org/10.1200/jco.2007.25.18_suppl.5520